Our Pricing

Online Prescription Weight Loss Medication UK: Expert Clinical Guidance

Published on: June 03, 2026

Seeking online prescription weight loss medication UK services with transparent pricing and expert clinical support? At Cured Pharmacy, our UK-registered prescribers assess your suitability for proven treatments including Mounjaro, Wegovy, Saxenda, and Orlistat—all available through a free consultation completed in under 3 minutes. Every medication is UK-licensed, dispensed by our GPhC-registered pharmacy, and delivered discreetly to your door.

How Prescription Weight Loss Medications Work in the UK

Prescription weight loss medications approved by the MHRA fall into two main categories: GLP-1 receptor agonists (such as tirzepatide, semaglutide, and liraglutide) and lipase inhibitors (such as orlistat). GLP-1 treatments mimic natural gut hormones that regulate appetite and blood sugar, reducing hunger signals and slowing gastric emptying [1]. Clinical trials demonstrate that these mechanisms can support substantial weight reduction when combined with lifestyle modifications.

Tirzepatide, the active ingredient in Mounjaro, represents the latest advancement—a dual GIP/GLP-1 receptor agonist that activates two complementary pathways. In the SURMOUNT-1 trial, participants achieved an average body weight reduction of 20.9% over 72 weeks at the highest dose, compared to 3.1% with placebo [1]. Semaglutide, found in Wegovy, demonstrated average reductions of 14.9% in the STEP 1 trial [2]. Orlistat works differently by blocking approximately 30% of dietary fat absorption in the digestive system [3].

Comparing GLP-1 Injections: Mounjaro, Wegovy, and Saxenda

Mounjaro (tirzepatide) delivers the most significant weight reduction outcomes currently available in UK clinical practice. As a dual-action medication, it provides superior efficacy compared to single-pathway GLP-1 treatments, with patients in clinical trials experiencing up to 22.5% body weight reduction at the 15mg maintenance dose [1]. The once-weekly KwikPen injection offers convenience and consistent therapeutic levels.

Wegovy (semaglutide) is administered once weekly and has demonstrated robust clinical outcomes across multiple STEP trials, with average weight reductions of approximately 15% when combined with lifestyle intervention [2]. Many patients find the once-weekly dosing schedule easier to maintain compared to daily injections. Saxenda (liraglutide) requires daily subcutaneous injection and typically produces moderate weight loss of 5-10% in clinical studies [4].

Your suitability for each treatment depends on your medical history, current medications, BMI, and weight loss goals. Our UK prescribers assess these factors during your online consultation to recommend the most appropriate option. All three medications require gradual dose escalation to minimise gastrointestinal side effects and optimise tolerability.

Which GLP-1 Treatment Suits Your Lifestyle?

Patients prioritising maximum efficacy and once-weekly convenience often prefer Mounjaro, whilst those seeking a well-established treatment with extensive real-world data may opt for Wegovy. Saxenda remains suitable for individuals who prefer lower upfront costs or have contraindications to higher-potency GLP-1 treatments. During your consultation, our prescribers review your preferences alongside clinical suitability to personalise your treatment plan.

Orlistat and Xenical: Fat Absorption Blockers for Weight Management

Orlistat offers a non-injectable alternative for patients seeking prescription weight loss medication. Available as generic orlistat 120mg or the branded Xenical formulation, this lipase inhibitor prevents approximately one-third of dietary fat from being absorbed in the intestines [3]. Clinical trials show average weight loss of 5-10% when combined with a reduced-calorie diet.

The medication works locally in the digestive system rather than systemically, making it suitable for patients who cannot tolerate GLP-1 treatments or prefer to avoid injections. Common side effects relate to fat malabsorption—including oily stools and increased bowel movements—which can be minimised by following a lower-fat diet (typically under 30% of daily calories from fat). Orlistat is available at competitive UK pricing, with generic formulations offering cost-effective options.

Lower-dose orlistat 60mg formulations (such as Alli and Orlos) are available without prescription for individuals with BMI 28 or above, though our prescribers can assess whether the higher 120mg prescription strength would provide better outcomes for your specific situation.

Generic vs Branded Orlistat: What's the Difference?

Generic orlistat 120mg and Xenical contain identical active ingredients and deliver equivalent clinical efficacy—both are licensed by the MHRA and manufactured to the same pharmaceutical standards. The primary difference is branding and price point. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), ensures all formulations dispensed meet rigorous UK quality requirements regardless of whether you choose generic or branded options.

Online Prescription Weight Loss Medication UK: The Consultation Process

Obtaining prescription weight loss medication through Cured Pharmacy begins with a confidential online consultation that takes under 3 minutes to complete. You'll answer medical history questions covering current health conditions, medications, allergies, and weight loss goals. Our UK-registered prescribers review every submission individually—there are no automated approvals.

The clinical assessment evaluates your BMI, any contraindications (such as thyroid conditions, pancreatitis history, or pregnancy), and whether prescription treatment is appropriate and safe. NICE guidelines recommend pharmacological intervention for adults with BMI ≥30 kg/m², or ≥27 kg/m² with weight-related comorbidities such as type 2 diabetes or hypertension [5]. Our prescribers follow these evidence-based criteria when making prescribing decisions.

If approved, your prescription is sent electronically to our GPhC-registered pharmacy (registration 9012511) for dispensing. Medications are dispatched in discreet, unmarked packaging with tracked delivery. If a prescriber determines that medication is not suitable, they will explain why and may suggest alternative approaches or recommend consultation with your NHS GP for further assessment.

Safety Considerations and Side Effects of Weight Loss Medications

GLP-1 receptor agonists commonly cause gastrointestinal side effects during the initial weeks of treatment, including nausea, diarrhoea, constipation, and reduced appetite. These effects typically diminish as your body adjusts to the medication [1][2]. Gradual dose escalation—standard protocol for Mounjaro, Wegovy, and Saxenda—helps minimise these symptoms. Staying well-hydrated and eating smaller, more frequent meals can further improve tolerability.

Rare but serious risks include pancreatitis, gallbladder disease, and thyroid C-cell tumours (observed in rodent studies but not conclusively linked in humans). GLP-1 medications are contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 [1]. Your prescriber will screen for these conditions during consultation.

Orlistat's side effects relate to its mechanism of blocking fat absorption—oily spotting, flatulence, and urgent bowel movements are common, particularly if you consume high-fat meals [3]. These effects serve as behavioural reinforcement to maintain a lower-fat diet. Orlistat can reduce absorption of fat-soluble vitamins (A, D, E, K), so multivitamin supplementation taken at least 2 hours apart from orlistat is recommended.

All prescription weight loss medications require ongoing monitoring. Report any severe abdominal pain, persistent vomiting, vision changes, or signs of allergic reaction to your prescriber immediately. Regular follow-up consultations ensure treatment remains safe and effective as you progress towards your weight loss goals.

When to Contact Your Prescriber

Seek immediate medical advice if you experience severe or persistent side effects, including continuous vomiting preventing fluid intake, severe abdominal pain radiating to the back, jaundice, or signs of dehydration. Our clinical team at Cured Pharmacy is available via phone (+44 116 4646009) to address concerns between consultations, ensuring you receive continuous support throughout your treatment journey.

Maximising Results: Lifestyle Modifications Alongside Medication

Prescription weight loss medications are most effective when integrated into a comprehensive lifestyle programme. Clinical trials demonstrating significant weight reduction included structured dietary counselling and physical activity recommendations [1][2]. The medications facilitate adherence to calorie reduction by suppressing appetite and cravings, but sustainable outcomes require behavioural changes.

NICE guidance recommends combining pharmacological treatment with a reduced-calorie diet (typically 500-600 kcal daily deficit) and at least 150 minutes of moderate-intensity physical activity per week [5]. GLP-1 medications make these targets more achievable by reducing hunger and increasing satiety—patients often report feeling satisfied with smaller portions and experiencing fewer food cravings.

Monitoring progress through regular weigh-ins, food diaries, and activity tracking helps maintain motivation and allows your prescriber to assess treatment efficacy. If weight loss plateaus or falls below expected outcomes (typically 5% body weight reduction within 12 weeks for orlistat, or ongoing reduction with GLP-1 treatments), your prescriber may adjust dosage, switch medications, or explore additional interventions.

Long-term weight maintenance requires ongoing commitment. Many patients continue medication for 12-24 months or longer, with prescribers periodically reviewing the need for continued treatment. Developing sustainable eating patterns and physical activity habits during the medication phase improves the likelihood of maintaining weight loss after treatment concludes.

Support Resources for Your Weight Loss Journey

Cured Pharmacy provides ongoing clinical support throughout your treatment. Our prescribers are available for follow-up consultations to review progress, adjust dosages, and address any concerns. We encourage patients to utilise NHS resources such as the Better Health programme for additional dietary and exercise guidance, complementing the pharmacological support provided by your prescribed medication.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
4. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
5. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (Clinical guideline CG189). NICE. https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary by individual and depend on adherence to lifestyle modifications alongside pharmacological treatment.